Blog
52 posts
InDream Healthcare: safer prescribing as a first step toward a healthier future
Read post →Hello, InDream Healthcare readers!
We are a digital healthcare company helping clinicians and patients access safer, more efficient care. We have been developing a clinical decision support system for both patients and physicians as part of our vision for digital health innovation. Today we introduce the problems we set out to solve and what we have achieved along the way.

A shared vision: InDream Healthcare’s journey of medical innovation
Read post →Hello, InDream Healthcare readers!
This is the second installment introducing the business model and commercialization strategy for the prescribing support system we are developing. We appreciate your continuing interest and support for our growth. Through this article, we share our plans and reflect together on our future direction.

Colchicine and drug interactions: an accessible guide
Read post →Hello, InDream Healthcare readers!
Today we explore colchicine, used to treat gout and inflammatory conditions, and its drug interactions. We will explain how it works and the precautions to consider in an accessible way.

Colchicine and cardiovascular disease: new possibilities
Read post →Hello, InDream Healthcare readers!
Continuing our previous discussion, today we share information on colchicine and cardiovascular disease. We hope it supports your health management.
Cardiovascular disease includes life-threatening conditions such as heart attacks and stroke. Recent studies suggest the possibility that colchicine, known as a gout treatment, may reduce cardiovascular risk. This article explores its effects and key study findings as potential new avenues for prevention.

InDream Healthcare’s CEO presents CARES reanalysis at the European rheumatology congress
Read post →Hello, InDream Healthcare readers!
Today we introduce recent activities and research by InDream Healthcare founder Professor Byeong-ju Kang. At the time of this article, he practiced rheumatology at Jeju National University Hospital, bringing extensive experience in medicine and healthcare. At the European rheumatology congress in Vienna, Austria, he presented research suggesting possibilities for reducing cardiovascular risk in patients with gout.

